North America Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Product, By End User, Based on Specimen, By Technology, By Application (Research, Clinical, and Drug/Therapy Development), By Country and Growth Forecast, 2024 - 2031

The North America Circulating Tumor Cell Market would witness market growth of 12.5% CAGR during the forecast period (2024-2031).

The US market dominated the North America Circulating Tumor Cell Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $6,117.7 million by 2031. The Canada market is experiencing a CAGR of 14.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 14% during (2024 - 2031).

Another key application of CTCs is in assessing the efficacy of cancer treatments. Traditional methods of evaluating treatment response, such as imaging and biopsies, can be invasive and may not provide immediate feedback.

Additionally, CTCs, on the other hand, allow for real-time monitoring of tumor behavior, offering insights into whether a treatment is working or if resistance is developing. This facilitates a more agile approach to oncology, enabling adjustments to the treatment plan before the cancer worsens.

The highest prevalence was observed in cancers such as breast, prostate, thyroid, colon, and cervical cancer. With this rising cancer burden, there is a growing need for more effective diagnostic and monitoring solutions. CTCs, a non-invasive method for detecting cancer cells circulating in the bloodstream, can revolutionize cancer diagnosis and treatment monitoring in Mexico. As the healthcare system in Mexico continues to improve and expand, the demand for advanced diagnostic tools like CTCs will grow, leading to increased market opportunities.

Free Valuable Insights: The Circulating Tumor Cell Market is Predict to reach USD 29.42 Billion by 2031, at a CAGR of 13.2%

Based on Product, the market is segmented into Kits & Reagents, Devices, and Blood Collection Tubes. Based on End User, the market is segmented into Research and Academic Institutes, Hospital & Clinics, and Diagnostic Centers. Based on Specimen, the market is segmented into Blood, Bone Marrow, and Other Specimen. Based on Technology, the market is segmented into CTC Detection & Enrichment Methods, CTC Analysis, and CTC Direct Detection. Based on Application, the market is segmented into Research, Clinical, and Drug/Therapy Development. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Qiagen N.V
• Greiner Bio-One International GmbH
• Sysmex Corporation
• Miltenyi Biotech B.V & Co kg
• Bio-Techne Corporation
• Ikonisys, Inc.
• Menarini Silicon Biosystems SpA
• LungLife AI Inc. 
• Aviva Systems Biology Corporation
• ScreenCell

North America Circulating Tumor Cell Market Report Segmentation

By Product

• Kits & Reagents
• Devices
• Blood Collection Tubes

By End User

• Research and Academic Institutes
• Hospital & Clinics
• Diagnostic Centers

By Specimen

• Blood
• Bone Marrow
• Other Specimen

By Technology

• CTC Detection & Enrichment Methods
• CTC Analysis
• CTC Direct Detection

By Application

• Research, Clinical
• Drug/Therapy Development

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Circulating Tumor Cell Market, by Product
1.4.2 North America Circulating Tumor Cell Market, by End User
1.4.3 North America Circulating Tumor Cell Market, by Specimen
1.4.4 North America Circulating Tumor Cell Market, by Technology
1.4.5 North America Circulating Tumor Cell Market, by Application
1.4.6 North America Circulating Tumor Cell Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Circulating Tumor Cell Market by Product
4.1 North America Kits & Reagents Market by Country
4.2 North America Devices Market by Country
4.3 North America Blood Collection Tubes Market by Country

Chapter 5. North America Circulating Tumor Cell Market by End User
5.1 North America Research and Academic Institutes Market by Country
5.2 North America Hospital & Clinics Market by Country
5.3 North America Diagnostic Centers Market by Country

Chapter 6. North America Circulating Tumor Cell Market by Specimen
6.1 North America Blood Market by Country
6.2 North America Bone Marrow Market by Country
6.3 North America Other Specimen Market by Country

Chapter 7. North America Circulating Tumor Cell Market by Technology
7.1 North America CTC Detection & Enrichment Methods Market by Country
7.2 North America CTC Analysis Market by Country
7.3 North America CTC Direct Detection Market by Country

Chapter 8. North America Circulating Tumor Cell Market by Application
8.1 North America Research, Clinical Market by Country
8.2 North America Drug/Therapy Development Market by Country

Chapter 9. North America Circulating Tumor Cell Market by Country
9.1 US Circulating Tumor Cell Market
9.1.1 US Circulating Tumor Cell Market by Product
9.1.2 US Circulating Tumor Cell Market by End User
9.1.3 US Circulating Tumor Cell Market by Specimen
9.1.4 US Circulating Tumor Cell Market by Technology
9.1.5 US Circulating Tumor Cell Market by Application
9.2 Canada Circulating Tumor Cell Market
9.2.1 Canada Circulating Tumor Cell Market by Product
9.2.2 Canada Circulating Tumor Cell Market by End User
9.2.3 Canada Circulating Tumor Cell Market by Specimen
9.2.4 Canada Circulating Tumor Cell Market by Technology
9.2.5 Canada Circulating Tumor Cell Market by Application
9.3 Mexico Circulating Tumor Cell Market
9.3.1 Mexico Circulating Tumor Cell Market by Product
9.3.2 Mexico Circulating Tumor Cell Market by End User
9.3.3 Mexico Circulating Tumor Cell Market by Specimen
9.3.4 Mexico Circulating Tumor Cell Market by Technology
9.3.5 Mexico Circulating Tumor Cell Market by Application
9.4 Rest of North America Circulating Tumor Cell Market
9.4.1 Rest of North America Circulating Tumor Cell Market by Product
9.4.2 Rest of North America Circulating Tumor Cell Market by End User
9.4.3 Rest of North America Circulating Tumor Cell Market by Specimen
9.4.4 Rest of North America Circulating Tumor Cell Market by Technology
9.4.5 Rest of North America Circulating Tumor Cell Market by Application

Chapter 10. Company Profiles
10.1 Qiagen N.V.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.6 SWOT Analysis
10.2 Greiner Bio-One International GmbH
10.2.1 Company Overview
10.2.2 SWOT Analysis
10.3 Sysmex Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Research & Development Expenses
10.3.4 SWOT Analysis
10.4 Miltenyi Biotech B.V. & Co. KG
10.4.1 Company Overview
10.4.2 SWOT Analysis
10.5 Bio-Techne Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Ikonisys, Inc.
10.6.1 Company Overview
10.7 Menarini Silicon Biosystems SpA
10.7.1 Company Overview
10.8 LungLife AI Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.9 Aviva Systems Biology Corporation
10.9.1 Company Overview
10.10. ScreenCell
10.10.1 Company Overview

TABLE 1 North America Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 2 North America Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 3 North America Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 4 North America Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 5 North America Kits & Reagents Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Kits & Reagents Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Devices Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Devices Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Blood Collection Tubes Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Blood Collection Tubes Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 12 North America Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 13 North America Research and Academic Institutes Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Research and Academic Institutes Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Diagnostic Centers Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Diagnostic Centers Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 20 North America Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 21 North America Blood Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Blood Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Bone Marrow Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Bone Marrow Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Other Specimen Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Other Specimen Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 28 North America Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 29 North America CTC Detection & Enrichment Methods Market by Country, 2020 - 2023, USD Million
TABLE 30 North America CTC Detection & Enrichment Methods Market by Country, 2024 - 2031, USD Million
TABLE 31 North America CTC Analysis Market by Country, 2020 - 2023, USD Million
TABLE 32 North America CTC Analysis Market by Country, 2024 - 2031, USD Million
TABLE 33 North America CTC Direct Detection Market by Country, 2020 - 2023, USD Million
TABLE 34 North America CTC Direct Detection Market by Country, 2024 - 2031, USD Million
TABLE 35 North America Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 36 North America Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 37 North America Research, Clinical Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Research, Clinical Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Drug/Therapy Development Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Drug/Therapy Development Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Circulating Tumor Cell Market by Country, 2020 - 2023, USD Million
TABLE 42 North America Circulating Tumor Cell Market by Country, 2024 - 2031, USD Million
TABLE 43 US Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 44 US Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 45 US Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 46 US Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 47 US Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 48 US Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 49 US Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 50 US Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 51 US Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 52 US Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 53 US Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 54 US Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 55 Canada Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 56 Canada Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 57 Canada Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 58 Canada Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 59 Canada Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 60 Canada Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 61 Canada Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 62 Canada Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 63 Canada Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 64 Canada Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 65 Canada Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 66 Canada Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 67 Mexico Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 68 Mexico Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 69 Mexico Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 70 Mexico Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 71 Mexico Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 72 Mexico Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 73 Mexico Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 74 Mexico Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 75 Mexico Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 76 Mexico Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 77 Mexico Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 78 Mexico Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 79 Rest of North America Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 80 Rest of North America Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 81 Rest of North America Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 82 Rest of North America Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 83 Rest of North America Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 84 Rest of North America Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 85 Rest of North America Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 86 Rest of North America Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 87 Rest of North America Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 88 Rest of North America Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 89 Rest of North America Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 90 Rest of North America Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 91 Key Information – Qiagen N.V.
TABLE 92 Key Information – Greiner Bio-One International GmbH
TABLE 93 Key Information – Sysmex Corporation
TABLE 94 Key information – Miltenyi Biotec B.V. & Co. KG
TABLE 95 Key Information – Bio-Techne Corporation
TABLE 96 Key Information – Ikonisys, Inc.
TABLE 97 Key Information – Menarini Silicon Biosystems SpA
TABLE 98 Key Information – LungLife AI Inc.
TABLE 99 Key Information – Aviva Systems Biology Corporation
TABLE 100 Key Information – ScreenCell

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Circulating Tumor Cell Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Circulating Tumor Cell Market
FIG 4 Porter’s Five Forces Analysis – Circulating Tumor Cell Market
FIG 5 North America Circulating Tumor Cell Market share by Product, 2023
FIG 6 North America Circulating Tumor Cell Market share by Product, 2031
FIG 7 North America Circulating Tumor Cell Market by Product, 2020 - 2031, USD Million
FIG 8 North America Circulating Tumor Cell Market share by End User, 2023
FIG 9 North America Circulating Tumor Cell Market share by End User, 2031
FIG 10 North America Circulating Tumor Cell Market by End User, 2020 - 2031, USD Million
FIG 11 North America Circulating Tumor Cell Market share by Specimen, 2023
FIG 12 North America Circulating Tumor Cell Market share by Specimen, 2031
FIG 13 North America Circulating Tumor Cell Market by Specimen, 2020 - 2031, USD Million
FIG 14 North America Circulating Tumor Cell Market share by Technology, 2023
FIG 15 North America Circulating Tumor Cell Market share by Technology, 2031
FIG 16 North America Circulating Tumor Cell Market by Technology, 2020 - 2031, USD Million
FIG 17 North America Circulating Tumor Cell Market share by Application, 2023
FIG 18 North America Circulating Tumor Cell Market share by Application, 2031
FIG 19 North America Circulating Tumor Cell Market by Application, 2020 - 2031, USD Million
FIG 20 North America Circulating Tumor Cell Market share by Country, 2023
FIG 21 North America Circulating Tumor Cell Market share by Country, 2031
FIG 22 North America Circulating Tumor Cell Market by Country, 2020 - 2031, USD Million
FIG 23 Swot Analysis: Qiagen N.V.
FIG 24 SWOT Analysis: Greiner Bio-One International GmbH
FIG 25 SWOT Analysis: Sysmex Corporation
FIG 26 Swot Analysis: Miltenyi Biotec B.V. & Co. KG
FIG 27 Swot Analysis: Bio-Techne Corporation